Crown Bioscience brings clarity to drug discovery around the world by helping biopharmaceutical companies solve some of today's most pressing challenges in oncology and inflammation.

Our premier Translational Platforms for cancer and inflammation help our clients accelerate their new drug development programs. We develop world-leading preclinical efficacy models and provide in vitro, in vivo and ex vivo testing services. We are a global CRO company with facilities in the UK, USA, Netherlands, China, and Taiwan.